首页|MECT联合药物治疗精神分裂症患者的效果及对血清BDNF、GFAP、PRL水平的影响

MECT联合药物治疗精神分裂症患者的效果及对血清BDNF、GFAP、PRL水平的影响

扫码查看
目的:探讨无抽搐电休克疗法(MECT)联合药物治疗精神分裂症患者的效果及对血清脑源性神经营养因子(BDNF)、胶质纤维酸性蛋白(GFAP)、催乳素(PRL)水平的影响.方法:纳入2021年1月—2023年5月江西省精神病院收治的82例精神分裂症患者,遵照随机数字表法将其分为观察组及对照组,各41例.对照组采用利培酮+奥氮平抗精神药物治疗方案,观察组在对照组基础上加用MECT干预.比较两组治疗前后精神状态[阳性与阴性症状量表(PANSS)]、认知状态[蒙特利尔认知评估量表(MoCA)]、记忆功能[韦氏记忆量表(WMS)]、执行功能[威斯康星卡片分类测验(WCST)]、血清指标(BDNF、GFAP、PRL)及不良反应发生情况.结果:治疗后,两组PANSS(阳性症状、阴性症状、一般精神病理评分)、WCST(错误应答数、首次分类应答数)、GFAP、PRL水平均较治疗前降低,且观察组水平均低于对照组,差异均有统计学意义(P<0.05).治疗后,两组MoCA评分、WMS(再认、图片、联想、背数记忆评分)、WCST(完成分类数、正确应答数、概念水平百分数)及BDNF水平均较治疗前升高(P<0.05),且观察组水平均高于对照组,差异均有统计学意义(P<0.05).两组不良反应比较,差异无统计学意义(P>0.05).结论:采用MECT联合抗精神药物治疗效果确切,可明显改善患者精神症状、认知、记忆及执行等功能障碍,改善脑营养状态,且安全性良好.
Efficacy of MECT Combined with Drug Therapy on Patients with Schizophrenia and Its Influence on Serum BDNF,GFAP and PRL Levels
Objective:To explore the efficacy of modified electroconvulsive therapy(MECT)combined with drug therapy in the treatment of patients with schizophrenia and its influence on serum levels of brain-derived neurotrophic factor(BDNF),glial fibrillary acidic protein(GFAP)and prolactin(PRL)levels.Method:A total of eighty-two patients with schizophrenia admitted to Jiangxi Mental Hospital from January 2021 to May 2023 were included,and were divided into observation group and control group by random number table method,with 41 cases in each group.The control group was given antipsychotic drugs with Risperidone+Olanzapine,and the observation group was added with MECT intervention on the basis of the control group.The mental state[positive and negative syndrome scale(PANSS)],cognitive state[Montreal cognitive assessment(MoCA)],memory function[Wechsler memory scale(WMS)],executive function[Wisconsin card sorting test(WCST)],serum indicators(BDNF,GFAP,PRL)and occurrence of adverse reactions were compared before and after treatment.Result:After treatment,the scores of positive symptoms,negative symptoms and general psychopathology of PANSS,error response count and first classified response count of WCST and levels of GFAP and PRL were reduced in both groups compared to those before treatment,and the those in observation group were lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the MoCA score,scores of recognition,picture,association and digit memory of WMS,completed classification count,correct response count and conceptual level percentage of WCST and level of BDNF in the two groups were all increased compared to those before treatment(P<0.05),and those in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).There was no difference in adverse reactions between the two groups(P>0.05).Conclusion:MECT combined with antipsychotic drug therapy has an exact efficacy,and it can significantly improve the mental symptoms,cognitive dysfunction,memory dysfunction and executive dysfunction,and enhance the brain nutrition state,with good safety.

Modified electroconvulsive therapyDrug therapySchizophreniaBrain-derived neurotrophic factorGlial fibrillary acidic proteinProlactin

朱虹、宋婷

展开 >

江西省精神病院临床治疗科 江西 南昌 330029

无抽搐电休克疗法 药物治疗 精神分裂症 脑源性神经营养因子 胶质纤维酸性蛋白 催乳素

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(19)
  • 20